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INTRODUCTION
Pulmonary sclerosing hemangioma (SH) was first described
by Liebow and Hubbell in 1956 (1). SH is thought to be a
rare benign neoplasm, but it has uncertain histogenesis and
biologic behavior. SH comprises a mixture of four histologic
patterns, such as papillary, sclerotic, solid and hemorrhagic.
SH consists of two cell types; eosinophilic cuboidal epithelial
lining cells and round cells with either eosinophilic or clear
cytoplasm forming sheets. The lining epithelial cells are te-
rmed as surface or cuboidal cells, while the other as round,
stromal, or lesional cells. Although SH originally termed a
variant of hemangioma (1), subsequent authors have suggest-
ed the origin of SH as mesenchymal (2), mesothelial (3) and
neuroendocrine (4) derivation. Now there is a consensus that
they are epithelial tumors (5, 6). The finding that SH has fea-
tures of a neoplasm was the reason for its being moved from
the category of tumor-like lesions in the 1981 World Health
Organization (WHO) classification of lung tumors (7) to the
category of miscellaneous tumors in the new 1999 WHO/
International Association for the Study of Lung Cancer clas-
sification (IASLC) (8). 
We reviewed the clinicopathologic features of sixteen cases
diagnosed as SH including five cases with unusual presenta-
tions.
MATERIALS AND METHODS 
All sixteen cases of pulmonary SH diagnosed in the Depart-
ment of Pathology, Samsung Medical Center, Seoul, Korea,
from 1996 to September, 2003 were retrieved (Table 1). The
surgical procedures included 11 cases of lobectomy and 5 cases
of wedge resection. All tumor tissues less than 5 cm were to-
tally embedded in paraffin block. Hematoxylin and eosin-
stained slides were reviewed to reconfirm the diagnosis and
to find the multiple histologic features by two experienced
pathologists. Medical records and surgical pathology reports
were also reviewed. Immunohistochemical stainings were
performed on paraffin-embedded tissue of all 16 cases using
labeled streptavidin-biotin peroxidase technique. The panel
of antibodies included anti-thyroid transcription factor-1
(TTF-1) (1:50, Dako, Glostrup, Denmark), anti-pancyto-
keratin (AE1/3, 1:80, Zymed, San Francisco, CA, U.S.A.),
anti-epithelial membrane antigen (EMA) (1:50, Dako), anti-
synaptophysin (1:40, Dako), chromogranin (1:2,000, Dako),
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Sixteen Cases of Sclerosing Hemangioma of the Lung Including
Unusual Presentations
Sclerosing hemangiomas (SH) of the lung are uncommon tumors and are thought
to be benign. However, the biologic behavior of this tumor has not yet been charac-
terized adequately. The clinicopathologic features were reviewed and analyzed for
16 cases of SH. The age of the patients ranged from 37 to 73 yr (mean 50.6 yr). There
were fifteen female and one male patient. The SH located at the intraparenchyme
in 14 cases, the interlobar fissure in one case and the visceral pleura in one case.
The size of SH ranged from 0.3 cm to 8 cm (mean 2.6 cm). There were five unusu-
al presentations of SH including a case having two SH with multiple nodules of atypi-
cal adenomatous hyperplasia in the same lobe, a case showing adenocarcinoma-
like area within the SH, a case showing one peribronchial lymph node metastasis
(N1 nodal stage) with location of interlobar major fissure, a case showing alveolar
adenoma-like area within the SH, and one case with a large visceral pleural-based
pedunculated mass presenting as mediastinal mass. All patients were alive and well
without recurrence at the last follow up. Here, we reviewed previously published lit-
eratures and discussed the histogenesis of SH.
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CD34 (1:100, Dako), CD56 (1:20, Monosan, Uden, Nether-
lands), smooth muscle actin (SMA) (1:100, Dako), p53 pro-
tein (BP 53.12, 1:400, Zymed) and Ki-67 (1:100, Dako). A
case was regarded as positive for TTF-1 if more than 10%
of the specific cell population showed nuclear staining.
RESULTS 
The mean age of the patients ranged from 37 to 73 yr (mean
50.6 yr). Among the 16 cases, there was marked female pre-
dominance, with a female to male ratio of 15:1. One case of
SH was located at the interlobar fissure of the lung, one was
Case Sex Procedure Location Unusual findings Major histologic patterns* Age (yr) Size (cm) F/U (yr)
1 F 55 W RML 3.0 6.8 P>>Sc>>So>H
2 F 37 L LLL 2.0 5.7 Regional LN (N1) metastasis  P>>Sc>H>So
Interlobar major fissure
3 M 37 L LLL 2.3 4.6 P>Sc>So>>H
4 F 58 L LLL 5.2 4.3 H>>>So>Sc>>P
5 F 55 L LLL 6.0 3.4 H>>Sc>So
6 F 43 L LUL 1.3 3.2 Adenocarcinoma-like area (0.4 cm) H>>P>>Sc
7 F 63 W RML 1.5 1.4 H=So>Sc>>P
8 F 68 W LLL 1.2 1.4 H>>So>>P
9 F 55 L RUL 1.5 1.3 H>>So>Sc>P
10 F 42 L RLL 1.2 1.2 Two SH P>>So>H>Sc
0.3 Multiple AAH-like area with papillae P>Sc (smaller)
11 F 73 L LUL 1.3 1.1 P>>Sc>H
12 F 36 L LLL 3.0 0.8 Alveolar adenoma-like area within SH P>H>>Sc
13 F 43 W RLL 1.3 0.5 Sc>>P>H
14 F 46 L RLL 2.2 0.4 H=P>Sc
15 F 59 W RML 8 0.2 Presenting as mediastinal mass H>>>So>P
16 F 40 L RML 2.7 0.1 P>H>Sc>So
Table 1. Clinicopathologic features of sclerosing hemangioma of the lung 
SH, sclerosing hemangioma; F/U, follow-up; L, lobectomy; W, wedge resection; RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe;
LUL, left upper lobe; LLL, left lower lobe; LN, lymph node; AAH, atypical adenomatous hyperplasia; P, papillary; H, hemorrhagic; Sc, sclerotic; So, solid.
*: dominant pattern in order.
A B C D
E F G H
Fig. 1. Four major histologic patterns and immunohistochemistry of the sclerosing hemangiomas. Sclerosing hemangiomas show papillary
(A), solid (B), sclerotic (C), and hemorrhagic (D) patterns. Sclerosing hemangioma consists of lining cuboidal cells (A) and stromal round
cells (B) (H&E stain: A, B ×200; C, ×100; D, ×1). Immunohistochemical stain shows that both lining cells and round cells are positive for
TTF-1 (E) and EMA (F), and CD56 (G). The pancytokeratin (H) reacts with the lining cells and focally reacts with round cells. (E to H, ×200).354 G.Y. Kim, J. Kim, Y.S. Choi, et al.
a visceral pleural-based pedunculated lesion and the rest were
intraparenchymal lesion. Six tumors were located at the left
lower lobe, four at the right middle lobe, three at right lower
lobe, two at the left upper lobe, and one at the right upper
lobe. The size of SH ranged from 0.3 cm to 8 cm (mean 2.6
cm) in 17 masses out of 16 cases. Macroscopically, the tumors
were rather well circumscribed and mostly pale yellowish
and dark red in color if they were of hemangiomatous variety.
The SH showed four distinct histologic patterns: papillary
(Fig. 1A), solid (Fig. 1B), sclerotic (Fig. 1C) and hemorrhagic
(Fig. 1D). The major histologic patterns composed of a vari-
able proportion of all four patterns in 9 out of 17 masses. He-
morrhagic pattern was observed in all except for the smallest
one (0.3 cm). All tumors composed of more than two histo-
logic patterns and none demonstrated a single pattern (Table
1). The tumors were composed of varying proportions of two
cell types, namely surface ‘lining cells’ or ‘cuboidal’, and pale
polygonal ‘lesional cells’ or ‘round cells’. These lining cells
resembling type II alveolar cells were most prominent in the
areas with papillary pattern (Fig. 1A). The round lesional cells
were pale round cells showed uniform, medium-size polyg-
onal nuclei with moderate amounts of pale, eosinophilic or
clear cytoplasm. The round cells were distributed in the inter-
stitial portion (Fig. 1A, B). Four out of 16 cases showed vac-
uolated clear epithelial lining cells. These cells reacted with
TTF-1, EMA and pancytokeratin immunostaining. Mitotic
figures were rarely seen in the cell population of the two cases.
There were scattered alveolar macrophages, multinucleated
giant cells, clumps of hemosiderin pigments, mast cells and
eosinophils. Occasionally psammoma bodies were seen in five
cases, cholesterol clefts in three cases and intralesional adipose
tissue in one case. Also seen were necroses in four cases. Lamel-
lar bodies were present in four cases (Table 2). Immunohis-
tochemical study showed that both surface cells and round
cells of SH were diffuse positive for TTF-1 in nucleus (Fig. 1E)
and EMA in cytoplasm (Fig. 1F), and negative for synapto-
physin, chromogranin, CD34 and SMA in all cases. CD56
focally reacted with the round cells in two cases (Fig. 1G).
Cytokeratin (AE1/3) reacted with the surface cells in all cases.
However, round cells rarely reacted with cytokeratin except
one case that showed focal positivity for cytokeratin (Fig. 1H).
The index of positivity of p53 protein ranged from negative












Calcification (psammoma bodies) 9 (5)
Necrosis 4
Intratumoral adipose tissue 1
Bronchiolar epithelial lining 7




Moderate to severe 5
Mitosis* 2 
Table 2. Histologic features of sclerosing hemangioma
*: less than 1/10 high power fields (HPFs).
No. Age (yr)/sex Site Tumor 
size (cm)*









1 10/F RML 4.7 1 Regional N1 2.3 (19)
2 45/F RUL 2.5 3 Hilar N1 4 (19)
3 45/M LLL 3.7 1 Peribronchial N1 2.5 (19)
4 56/F LLL 1.5 1 Interlobar N1 10 (19)
5 18/F LLL 3 2 Peribronchial N1 NA (6)
6 22/M RLL 5 1 Hilar N1 2.3 (13)
7 48/M RLL 8 2 Hilar N1 NA (5)
8 NA/NA NA NA 1 Hilar N1 NA (14)
9 19/F LLL 10 11 Hilar (5) N1 NA (20)
interlobar (2)
intrapulmonary (4)
10 67/F RLL 9 5 3, 7, 9, 11s, 11i N2, N1 2 (18)
11 29/M RUL 3 4 Regional N1 1 (15)
12 53/M LLL 3.5 1 Subcarina N2 1 (17)
13 NA NA NA NA NA NA NA (16), cited in (13)
14 37/F LLL 2 1 Peribronchial N1 5.7 Current case
Table 3. Metastasizing pulmonary sclerosing hemangioma
LN, lymph node; NA, not available; RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe.
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ranged from negative to 10% (mean 4.5%). 
We experienced five unusual presentations of SH including
one case with two nodules (1.2 cm and 0.3 cm) and multiple
small atypical alveolar hyperplasia (AAH)-like nodules in
background of the lung parenchyma. One case showed pap-
illary adenocarcinoma-like area, and one case with one SH
having regional lymph node metastasis. One case showed an
alveolar adenoma-like area, and one case revealed a visceral
pleural-based pedunculated mass that presented as a mediasti-
nal mass clinically. The first case is a 42-yr-old female patient
who was found to have a right lower lobe mass on chest radio-
graph without subjective symptoms. The surgeon found two
nodules of the same lobe in the operating field. The size of the
two tumors were 1.2 cm and 0.3 cm, respectively (Fig. 2A,
B). The first case of 1.2 cm sized nodule showed four histo-
logic patterns of papillary, solid, sclerotic and hemorrhagic,
and focal mild atypia. The second case of the smaller nodule
showed two histologic patterns of papillary and sclerotic. We
could also find twelve small-sized AAH-like nodules with
some papillae and micropapillae in background lung parenchy-
ma of same lobe (Fig. 2C). The histology was similar to that
of alveolar adenoma or AAH, but these had papillary or mi-
cropapillary structure and variably distributed irregular pat-
tern. The tumor cells showed interstitial oval to spindle cell
proliferation. The size of the small nodules ranged from 0.1
cm to 0.7 cm (mean 0.35 cm). Immunohistochemically, the
lining cells of the small nodular lesion reacted with TTF-1
and EMA, and the interstitial stromal cells were focally pos-
itive for TTF-1 (Fig. 2D) and EMA. The second was a 37-yr-
old female patient who presented with a 2 cm sized SH with
one peribronchial regional lymph node metastasis (nodal stage,
N1). A metastatic focus of the lymph node, measuring 0.1 cm,
was noted. The metastatic tumor cells showed predominantly
papillary structure lined by cuboidal cells and round cells (Fig.
2E). Both tumor cells also reacted with TTF-1 and EMA im-
munostaining. The third case was a 36-yr-old female patient
with a 3 cm sized tumor with alveolar adenoma-like area
peripherally to the main mass. The alveolar adenoma-like area
continued to the main mass and had thin-walled multiple
cystic spaces lined by low cuboidal cells, measuring 1 cm in
length (Fig. 2F). The fourth case was a 59-yr-old female pa-
tient who presented with a mediastinal mass. Chest computed
A B C D
E F G
Fig. 2. Unusual presentations of the sclerosing hemangiomas. Two sclerosing hemangiomas (A, B) with atypical alveolar hyperplasia-like
nodule (C) in the background lung parenchyme (H&E stain: A, B, ×1; C, ×200). Atypical alveolar hyperplasia-like nodule shows that the
lining cells and some stromal cells are positive for TTF-1 (D) immunostaining (×400). (E) One sclerosing hemangioma with lymph node metas-
tasis (H&E stain, ×200). (F) One sclerosing hemangioma with an alveolar adenoma-like area in the upper half (H&E stain, ×100). (G) One
sclerosing hemangioma with adenocarcinoma-like area (H&E stain, ×100).356 G.Y. Kim, J. Kim, Y.S. Choi, et al.
tomography showed a large pleural based mass that was locat-
ed adjacent to the right cardiac border. On gross examination,
the mass measured 8 cm in the greatest diameter, and was in
continuity with the right middle lobe of the lung. The tumor
displayed three major histologic patterns of SH; predominantly
hemorrhagic, solid and papillary. The areas showing hemor-
rhagic pattern were composed of large blood-filled spaces lined
by epithelial cells and were reminiscent of a cavernous heman-
gioma (Fig. 1D). This case was proven as SH by gross exami-
nation, operative record, histologic features and immunohis-
tochemical study. The last case was a 43-yr-old female patient
with one 1.3 cm sized tumor with an adenocarcinoma-like
area, measuring 0.4 cm in the longest diameter (Fig. 2G). But
there were no mitotic figures and no definite stromal invasion.
Flow cytometery for the SH was performed and showed dip-
loid. The Ki-67 labeled proliferating index and the index of
p53 protein were 5% and 20%, respectively. The histologic
pattern was mixed with hemorrhagic, papillary and sclerotic.
All 16 patients were alive and well without recurrence or
metastasis during a follow-up period of 1 month to 6.8 yr
(mean 2.3 yr). 
DISCUSSION 
SH is a rare primary pulmonary tumor and is thought to
be benign tumor. However, the biologic behavior of this tumor
has not yet been characterized adequately. The histogenesis
of the SH also remains a subject of debate. Although SH orig-
inally termed a variant of hemangioma (1), subsequent authors
have suggested the origin of SH as mesenchymal (2), mesothe-
lial (3) and neuroendocrine (4) derivation. Now, there is a con-
sensus that they originated from primitive epithelial cells (5,
6). The epithelial origin of the tumor was also supported by
TTF-1 and EMA positivity in both the surface cells and round
cells in the majority of the cases (6, 9). TTF-1 is expressed
in the thyroid, lung, and the diencephalons of the brain. In
the lung, it binds to the surfactant A, B, C and Clara cell
secretory protein genes. It is expressed in the non-ciliated
columnar cells of the fetal lung as early as 11 weeks of gesta-
tion, and in type II pneumocytes and Clara cells of the adult
lung (10, 11). The TTF-1 expression of both cells supported
that both cells were derived from a primitive respiratory cell
or may represent incompletely differentiated pneumocytes or
Clara cells (5, 6, 12). Pancytokeratin (AE1/3) usually reacts
with surface cells, and not with round cells. However, round
cells rarely reacted with cytokeratin except one case that show-
ed focal positivity for cytokeratin. The immunohistochemical
findings of the round cells were positive for TTF-1 and cytok-
eratin, suggesting that intermediate differentiation between
differentiated epithelial cuboidal cells and undifferentiated
round pale cells (5, 6). 
Although it is thought to be benign, rare cases apparently
showed metastatic potential. In 1986, Tanaka and colleagues
reported the first case of SH with lymph node metastasis (13).
We found thirteen cases in nine previously reported literatures
with metastasizing pulmonary SH (Table 3) (5, 6, 13-20).
Including the current case, there were seven cases of single
lymph node metastasis and six cases of multiple (>2) lymph
nodes metastases. Two cases of mediastinal (nodal stage, N2)
lymph node metastases were found (17, 18). Distant hema-
togenous metastasis from SH has not been reported. The pri-
mary tumor size ranged from 1.5 to 10 cm (mean 4.7 cm).
We assumed that the primary tumor size and male ratio in
the metastasizing pulmonary SH had increased as compared
to the population with no lymph node metastasis, however
we do not have statistical data. In the 9 cases, including one
current case, their follow-up periods were available. The mean
time was 3.4 yr (ranging from 1 to 10 yr) (Table 3). The me-
tastatic lymph node of the current case also showed both sur-
face and round cells like that of previously described cases.
There was no recurrence or no metastasis during the follow-
up period. The prognosis did not appear to be affected by the
presence of regional lymph node metastases. There were evi-
dences which regarded both surface and round cells as neopla-
sia. A study using microdissection technique demonstrated
that both surface cells and round cells of SH showed similar
clonality and represented a variable differentiation from a com-
mon progenitor cell (21). 
A few series have described multiple SH (6, 14, 22-29) and
the incidence was 4-5% (6, 24, 26, 28). To our knowledge, two
cases of bilateral multiple SH were described in the English-
language literature (27, 29). The possible pathogenesis of
multiple SH has not been established. The cases of AAH in
continuity with multiple SH (25), alveolar adenoma with SH
(17), and transition from atypical hyperplasia of type II pneu-
mocyte to SH (29) have been described. The reports suggested
that AAH of type II pneumocytes could be a focus of atypical
growth of lining epithelial cells of SH. In our series, there was
one case of alveolar adenoma-like area in the peripheral por-
tion of the SH. Another case with two SH had a background
of multiple AAH with papillae in the right lower lobe. We
did not investigate other studies for the postulation except for
an immunohistochemical study. We could not verify whether
this case indicated multicentric origin of the SH or intrapul-
monary metastasis, or incidental findings. Even if the AAH-
like lesion with papillae is presumptive precursor lesion of
SH, there are limitations for the postulation so far. A longer
follow-up data, ample cases, and further studies are needed
to support that. 
The SH could be presented clinically with mediastinal mass,
and be located at the interlobar fissure (6, 30). These histologic
patterns were predominantly hemorrhagic or angiomatous
like that of cavernous hemangioma. Sakamoto et al. (31) re-
ported a case of SH isolated in the mediastinum, and suggest-
ed the hypothesis of three mechanism that may account for
the development of mediastinal SH. The first was metastasis
from the lung to the mediastinum. The second mechanismUnusual Presentations of Pulmonary Sclerosing Hemangioma 357
was that the tumor could have originated from ectopic lung
tissues, such as bronchogenic cysts. The final mechanism was
that the SH developed from the lung as a pedunculated pleu-
ral mass that slowly pulled away from the lung surface. All
three of these potential mechanisms are plausible; however,
the first mechanism was against findings that all previously
reported cases of lymph node metastasis from SH had evidence
of primary tumor. A case report of SH arising in the extrapul-
monary sequestration was described in the English literature
and may support the second mechanism (32). In the cases that
presented as a pleural based or mediastinal mass, the contrib-
utor did not initially consider the diagnosis of SH. However,
after careful review of the operative findings, chest radiographs,
and histologic findings, it was apparent that these lesions arose
from the periphery of the lung and protruded from the vis-
ceral pleural surface, giving the initial impression of an extra-
pulmonary origin (6, 33). Our current case which presented
mediastinal mass also revealed a pulmonary origin after check
of additional gross examination, operative findings, and com-
patible immunohistochemical studies. 
Based on the findings of higher incidence in females, Leong
et al. (28) and Aihara and Nakajima (34) studied both estro-
gen receptors (ER) and progesterone receptors (PR) immuno-
histochemically. They reported that most patients were pos-
itive for both ER and PR, suggesting a relationship between
this tumor and female sex hormones. 
Variable degrees of cytologic atypia were found in most
SH. In our series, one case showed a focus of papillary adeno-
carcinoma-like area within the SH, measuring 0.4 cm in the
longest diameter, and mitotic figure was not absent. Fine nee-
dle aspiration was performed in ten out of sixteen patients of
our series. The diagnoses included insufficient specimen in
four, malignancy versus SH in two and suspicion of adenocar-
cinoma in four. The severe cytologic atypia made it difficult
to make a diagnosis of SH in aspiration cytology. The above
findings; lymph node metastasis, severe atypia, and multifo-
cal distribution, may suggest that SH is a low grade malig-
nancy. However, SH is a clinically benign tumor and has a
good prognosis. All our current cases showed no recurrent or
metastasis after excision, and the patients all are alive and well
at present. 
In conclusion, SH may show hilar or mediastinal lymph
nodes metastases, cytologically severe atypia, and multicen-
tricity. But, these unusual features do not affect the prognosis.
Complete excision of lesion is a curable treatment method
and leads to an excellent prognosis. Further studies on many
cases of SH are necessary to elucidate the mechanism of metas-
tasis, multiplicity, and extrapulmonary manifestation.
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